China hits back with sanctions on lockheed, raytheon

China sanctioned American defense contractors Lockheed Martin Corp. and a subsidiary of Raytheon Technologies. It's a further ...

February 17, 2023, 4:42 pm

Justice department steps up apple antitrust probe

A federal investigation targeting Apple is reportedly escalating amid a wave of corporate antitrust actions. While the U.S. Justice Department probe...

February 15, 2023, 2:28 pm

Southern company (so) q4 earnings on deck: what to expect

While new customer additions are likely to have boosted Southern Company's (SO) profit levels in the fourth quarter, ...

February 14, 2023, 9:47 am

Marathon (mro) to report q4 earnings: what's in store?

While strong commodity prices are likely to have boosted Marathon Oil's (MRO) fourth-quarter results, escalati...

February 13, 2023, 9:47 am

Suncor's (su) q4 earnings preview: key things to consider

While strong refined product sales are likely to have boosted Suncor Energy's (SU) fourth-quarter results, esc...

February 10, 2023, 10:32 am

Amazon uk strikes may 'escalate' as workers plan next steps

Striking British Amazon.com Inc (NASDAQ:AMZN) employees are meeting today to plan a potential "escalation" of industrial action. Last month, workers a...

February 9, 2023, 11:02 am

Google ceo issues rallying cry in internal memo: all hands on deck to test chatgpt competitor bard

The escalation in urgency comes as the company ups its rivalry with Microsoft-backed OpenAI, whose Chat...

February 6, 2023, 5:21 pm

Can the cost-of-living crisis be a major catalyst for fintech growth?

With the words recession and inflation being tossed around more frequently, consumers seem scared of a potential ...

February 2, 2023, 9:34 am

Eur/usd: euro remains in question ahead of eu gdp

I remind that lately the European common currency has discounted several positive data for it, such as the significant de-...

January 31, 2023, 9:29 am

Us is moving towards sending abrams tanks to ukraine - report

An unnamed official cited by Reuters said the US is moving towards sending Abrams tanks to Ukraine.

You have to wonder when the ...

January 24, 2023, 3:11 pm

Viracta therapeutics announces first clinical response in epstein-barr virus-positive (ebv+) solid tumor setting and outlines key 2023 clinical objectives

Partial response (PR) observed in third dose level of the Phase 1b dose escalation study of Nana-val in...

January 8, 2023, 6:00 pm

Hyderabad: gold price sees sudden spike, bullion traders worried

Market experts say that surge is majorly due to the US Fed meeting minutes outcome that will come out this week, weakening Indian rupee and the fears ...

January 4, 2023, 4:14 am

European stocks tumble, end final session of year on weak note

European stocks ended the final session of Year 2022 on a very weak note as fears about a recession, worries about rising rates, surging Covid cases i...

December 30, 2022, 5:27 pm

Eur/usd struggles to defend 1.0600 as market fears renew us dollar demand

EUR/USD holds lower grounds after closely avoiding the 1.0600 breakdown. Distrust on China unlock, global restrictions on travelers from Beijing rever...

December 28, 2022, 11:44 pm

Genprex gets green light for continuation of dose escalation phase 1 of acclaim-1 phase 1/2 clinical trial of reqorsa

Genprex, Inc. (NASDAQ:GNPX) has announced that the Safety Review Committee (SRC) has approved continuation to the third and final cohort in the dose <...

December 14, 2022, 8:27 am

Fate therapeutics highlights ipsc-derived, off-the-shelf car nk cell programs for multiple myeloma at 2022 ash annual meeting

Interim Phase 1 Data of FT576 BCMA-targeted Product Candidate Show Clinical Activity in Initial Single-dose es...

December 10, 2022, 7:46 pm

Fate therapeutics announces clinical safety and activity data of first-ever ipsc-derived car t-cell therapy at 2022 ash annual meeting

FT819 Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Engineered Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC...

December 10, 2022, 3:00 pm

Olema oncology announces op-1250 demonstrates attractive combinability with cdk 4/6 inhibitor palbociclib in phase 1b dose escalation study

OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- breast cancer, with no dose-limiting toxicities, and no observed...

December 7, 2022, 8:37 pm

Viracta therapeutics announces preliminary dose-ranging data from the phase 1b/2 trial of nana-val in advanced epstein-barr virus-positive (ebv+) solid tumors at the esmo immuno-oncology congress

Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose ...

November 30, 2022, 11:10 pm

Markets cautious, awaiting eurozone cpi and development in china

Overall, the forex markets are very cautious for now, awaiting the key events of the week, including Eurozone CPI flash today and US non-farm payrolls...

November 30, 2022, 6:13 am